拉呋替丁

Lafutidine

未知生产厂商

Lafutidine has been investigated in Peptic Ulcer, Community-acquired Pneumonia, and Gastroesophageal Reflux Disease (GERD).

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Lafutidine has been investigated in Peptic Ulcer, Community-acquired Pneumonia, and Gastroesophageal Reflux Disease (GERD).

用于十二指肠溃疡和胃溃疡。

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Lafutidine compound and novel preparation method of lafutidine compound
申请人: HAINAN MEILANSHIKE PHARMA CO优先权: 2012
CN
Lafutidine pharmaceutical composition
申请人: SZYY GROUP PHARMACEUTICAL LTD优先权: 2024
CN
Preparation method of lafutidine
申请人: SZYY GROUP PHARMACEUTICAL LTD优先权: 2024
CN
Reducing preparation method for lafutidine
申请人: BEIJING DOUBLE CRANE PHARMACEUTICAL CO LTD优先权: 2010
CN
Lafutidine injecta and its prepn
申请人: HUANG ZHENHUA优先权: 2002
CN
Lafutidine Tablet and its preparation method
申请人: JIANGSU RUNBANG PHARMACEUTICAL优先权: 2007
CN
Lafutidine gastric-retention controlled-release composition
申请人: SHANDONG QIDU PHARMACEUTICAL优先权: 2010
CN
Method for preparing lafutidine key intermediate
申请人: JIANGSU PHARMSYN PHARMACEUTICAL TECH CO LTD优先权: 2023
CN